日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Validation of histopathology-based deep learning algorithms for detection of actionable non-small cell lung cancer biomarkers

验证基于组织病理学的深度学习算法在检测可操作的非小细胞肺癌生物标志物方面的有效性

Rolfo, Christian; Ofek, Efrat; Barak, Yoash; Weidenfeld, Jonathan; Haj, Razan Imad; Molchanov, Yosef; Loebel, Alexander; Braxton, David R; Cupp, John S; Yacobi, Rinat; Mayer, Chen; Drago, Francesco; Avivi, Camila; Paz-Yaacov, Nurit; Avinoam, Assaf; Zalach, Jonathan; Dvir, Addie; Gazy, Inbal; Peled, Nir; Urban, Damien; Bar, Jair; Hershkoviz, Dov; Barshack, Iris

High-Dose Twice-Daily Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Real-World Retrospective Experience from Two Tertiary Centers

高剂量每日两次胸部放射治疗局限期小细胞肺癌:来自两家三级医疗中心的真实世界回顾性经验

Icht, Oded; Krayim, Bilal; Moskovitz, Mor; Reinhorn, Daniel; Rotem, Ofer; Averbuch, Itamar; Peled, Nir; Allen, Aaron M

Amivantamab as a salvage therapy post-EGFR-tyrosine kinase inhibitor failure in patients with mutated EGFR non-small cell lung cancer

阿米万单抗作为EGFR酪氨酸激酶抑制剂治疗失败后EGFR突变型非小细胞肺癌患者的挽救治疗

Krayim, Bilal; Kian, Waleed; Spector, Maria; Granot, Inbal; Dudnik, Julia; Nissim, Michal; Kahala, Dolev; Remilah, Areen Abu; Bogot, Naama R; Kornev, Gleb; Asna, Noam; Peled, Nir; Roisman, Laila C

Characterization of the xeno-GVHD response generated by advanced lung cancer patient peripheral blood mononuclear cells in NSG-SGM3 mice

对NSG-SGM3小鼠中由晚期肺癌患者外周血单核细胞产生的异种移植物抗宿主病(xeno-GVHD)反应进行表征

Fuchs, Vered; Roisman, Laila; Msamra, Maha; Refaely, Yael; Cohen, Aharon Yehonatan; Porgador, Angel; Peled, Nir; Sobarzo, Ariel

Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50

晚期非小细胞肺癌中程序性死亡配体1肿瘤比例评分≥50的基于肺免疫预后指数的预测评分

Raphael, Ari; Kamm Feldman, Ayelet; Lazarev, Irina; Kian, Waleed; Peled, Nir; Hod, Keren; Shalata, Walid; Dudnik, Elizabeth

Osimertinib before and after chemoradiotherapy for unresectable stage III EGFR-mutated NSCLC: NEOLA Trial Protocol

奥希替尼在不可切除的III期EGFR突变型非小细胞肺癌患者接受放化疗前后的疗效:NEOLA试验方案

Aredo, Jacqueline V; Peled, Nir; Arriola, Edurne; Wakelee, Heather; Ahn, Myung-Ju; Kwint, Margriet H; Taylor, Rosemary; van der Gronde, Toon; Nasirova, Feruza; Chen, Ming

MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy

MOMENT登记研究:接受全身治疗的携带MET外显子14跳跃突变的晚期非小细胞肺癌患者

Thomas, Michael; Christopoulos, Petros; Iams, Wade T; Mazières, Julien; Cortot, Alexis B; Peled, Nir; Minuti, Gabriele; Smit, Egbert F; Audhuy, Francois; Berghoff, Karin; Eggleton, S Peter; Fries, Frank; Hildenbrand, Maike; Liu, Peter; Mahmoudpour, Seyed Hamidreza; Menzel, Christoph; Oksen, Dina

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer

非小细胞肺癌组织和循环肿瘤(ct)DNA二代测序结果报告建议

Malapelle, Umberto; Leighl, Natasha; Addeo, Alfredo; Hershkovitz, Dov; Hochmair, Maximilian J; Khorshid, Ola; Länger, Florian; de Marinis, Filippo; Peled, Nir; Sheffield, Brandon S; Smit, Egbert F; Viteri, Santiago; Wolf, Jürgen; Venturini, Filippo; O'Hara, Richard M Jr; Rolfo, Christian

Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer

病例报告:诱导靶向治疗对III期驱动突变型非小细胞肺癌的影响

Kian, Waleed; Krayim, Belal; Giles, Betsy; Elkiaan, Nasim A; Idris, Amjad; Fink, Daniel; Peled, Nir; Roisman, Laila C

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

帕博利珠单抗联合培美曲塞和铂类药物治疗非鳞状非小细胞肺癌:KEYNOTE-189 III期研究的5年结果

Garassino, Marina C; Gadgeel, Shirish; Speranza, Giovanna; Felip, Enriqueta; Esteban, Emilio; Dómine, Manuel; Hochmair, Maximilian J; Powell, Steven F; Bischoff, Helge G; Peled, Nir; Grossi, Francesco; Jennens, Ross R; Reck, Martin; Hui, Rina; Garon, Edward B; Kurata, Takayasu; Gray, Jhanelle E; Schwarzenberger, Paul; Jensen, Erin; Pietanza, M Catherine; Rodríguez-Abreu, Delvys